๐ŸŽ Black Friday: up to 50% off of annual plans
NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea flag South Korea ยท Delayed Price ยท Currency is KRW
1,410.00
-75.00 (-5.05%)
Nov 20, 2026, 3:30 PM KST

NeoImmuneTech Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
6,60294.82170.38---
Revenue Growth
6902.30%-44.35%----
Gross Profit
4,39894.82170.38---
Operating Income
-20,631-25,339-40,972-55,847-58,182-51,906
Net Income
-22,846-31,796-40,883-53,405-60,406-52,482
Earnings Per Share
-179.07-270.20-414.60-540.40-611.60-550.94
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
38,11360,82234,61969,072117,075154,471
Total Debt
11,56610,49210,7713,9084,8515,795
Net Cash (Debt)
26,54750,33023,84965,164112,224148,676
Net Cash Growth
-55.70%111.04%-63.40%-41.93%-24.52%117.64%
Net Cash Per Share
208.09427.71241.85659.231136.261560.75

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-17,225-25,053-39,062-49,761-42,405-33,887
Capital Expenditures
-91.78-79.64-1,549-791.39-2,477-2,710
Free Cash Flow
-17,316-25,133-40,612-50,552-44,881-36,596
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
66.61%100.00%100.00%---
Operating Margin
-312.48%-26721.84%-24047.07%---
Pretax Margin
-345.46%-33543.38%-23987.05%---
Profit Margin
-346.02%-33531.39%-23994.58%---
FCF Margin
-262.28%-26504.37%-23835.33%---

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
21.114280.053263.98---